MGXMF yields 2000000.00% · PFE yields 6.13%● Live data
📍 MGXMF pulled ahead of the other in Year 1
Combined, MGXMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MGXMF + PFE for your $10,000?
MGX Minerals Inc. engages in the acquisition, exploration, and development of mineral resource properties and industrial technologies. The company operates and invests in mineral property portfolios, which consists of lithium, magnesium oxide, silca, niobium-tantulum, and gold properties located in Canada. It holds 100% interests in Fran Property located within the Omineca Mining District, British Columbia; Longworth Silica Property; Wonah mineral claims; Alberta Lithium property; and Gibraltar Claims. The company also holds a 90% interest in Driftwood Property, as well as interests in Koot Silica Property; Sturgeon Lake Lithium Brine Property; REN mineral claims; Kibby Basin; and HeinoMoney Gold deposit and Tillicum claims. In addition, it owns, operates, and sells water treatment systems to the oil and gas industry; and owns lithium extraction technology from brine, which eliminates the need for solar evaporation. The company is headquartered in Vancouver, Canada.
Full MGXMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.